Supriya Lifescience posts 50% revenue growth in Q4 FY26; PAT rises to Rs 74 crore
On a full-year basis, revenue from operations for FY26 grew 18.9 percent year-on-year to Rs 827.87 crore compared to Rs 696.48 crore in FY25
On a full-year basis, revenue from operations for FY26 grew 18.9 percent year-on-year to Rs 827.87 crore compared to Rs 696.48 crore in FY25
The device is designed for early and accurate diagnosis of obstructive airway diseases such as COPD, and Asthma
New pediatric nebulizer combines playful design and engaging features to make breathing treatments less stressful for children and parents
Appointment strengthens Medanta’s pediatric super-specialty and respiratory care services in the Delhi-NCR region.
The CE Mark builds on the company’s ISO 13485 certification, further strengthening confidence in the platform's safety, quality and performance
The drug meets all primary endpoints across 608 patients in Europe and India, strengthening the company's biosimilars pipeline
Safety was equally impressive. ENV-294 was well tolerated
The move leverages Novartis’ deep expertise in IgE biology and long-standing presence in allergic disease treatments
The study hit its primary goal, showing a statistically significant rise in participants achieving EASI-75
The data highlights its RSV vaccine cuts hospitalizations in older adults
Subscribe To Our Newsletter & Stay Updated